CLOV vs XPER
Clover Health Investments Corp (CLOV) versus Xperi Corp (XPER) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Xperi Corp (XPER) is a software - application company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported XPER revenue for 2024-12-31 was $493.7M. Net income was -$869.0K. Revenue was down 5.3% from 2023-12-31 to 2024-12-31. XPER currently screens at market cap $367.8M.
CLOV currently screens at market cap $1.55B. XPER currently screens at market cap $367.8M.
Not investment advice. Open the CLOV and XPER stock pages for the full models.
Not investment advice.